{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:35:08Z","timestamp":1791228908449,"version":"4.1.0"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.18895","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T13:02:11Z","timestamp":1627909331000},"page":"e2118895","source":"Crossref","is-referenced-by-count":26,"title":["Association of Sodium Thiosulfate With Risk of Ototoxic Effects From Platinum-Based Chemotherapy"],"prefix":"10.1001","volume":"4","author":[{"given":"Chih-Hao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Yuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Yu Haley","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Che","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"zoi210562r1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","article-title":"Cisplatin in the modern era: the backbone of first-line chemotherapy for non\u2013small cell lung cancer.","volume":"44","author":"Fennell","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"zoi210562r2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0971-9261.142001","article-title":"The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials.","volume":"19","author":"Aronson","year":"2014","journal-title":"J Indian Assoc Pediatr Surg"},{"issue":"15","key":"zoi210562r3","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","article-title":"Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.","volume":"23","author":"Gibson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi210562r4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer.","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"zoi210562r5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action.","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"zoi210562r6","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1021\/acs.jmedchem.7b01653","article-title":"Progress in the development of preventative drugs for cisplatin-induced hearing loss.","volume":"61","author":"Hazlitt","year":"2018","journal-title":"J Med Chem"},{"issue":"11","key":"zoi210562r7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1097\/00005537-200211000-00016","article-title":"Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001.","volume":"112","author":"Blakley","year":"2002","journal-title":"Laryngoscope"},{"issue":"8","key":"zoi210562r8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2352-4642(19)30115-4","article-title":"Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.","volume":"3","author":"Freyer","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"1-2","key":"zoi210562r9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.heares.2004.12.007","article-title":"Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs.","volume":"203","author":"van Ruijven","year":"2005","journal-title":"Hear Res"},{"issue":"1","key":"zoi210562r10","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy.","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"zoi210562r11","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.","volume":"5","author":"van As","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"sup4","key":"zoi210562r12","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1080\/14992027.2018.1455114","article-title":"Protection for medication-induced hearing loss: the state of the science.","volume":"57","author":"Hammill","year":"2018","journal-title":"Int J Audiol"},{"issue":"5","key":"zoi210562r13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ctrv.2006.04.011","article-title":"Future opportunities in preventing cisplatin induced ototoxicity.","volume":"32","author":"van den Berg","year":"2006","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"zoi210562r14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08880010590964381","article-title":"Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.","volume":"22","author":"Sastry","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"issue":"22","key":"zoi210562r15","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2007.14.3974","article-title":"Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.","volume":"26","author":"Fouladi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi210562r16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1023\/A:1008353505916","article-title":"Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer.","volume":"10","author":"Planting","year":"1999","journal-title":"Ann Oncol"},{"issue":"5","key":"zoi210562r17","first-page":"309","article-title":"Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.","volume":"41","author":"Duval","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"6","key":"zoi210562r18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/08880010701451244","article-title":"Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.","volume":"24","author":"Gallegos-Castorena","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"issue":"24","key":"zoi210562r19","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1002\/cncr.v115:24","article-title":"Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children\u2019s Oncology Group.","volume":"115","author":"Katzenstein","year":"2009","journal-title":"Cancer"},{"issue":"suppl_2","key":"zoi210562r20","doi-asserted-by":"publisher","first-page":"i127","DOI":"10.1093\/neuonc\/noy059.444","article-title":"Hearing chemoprotection with sodium thiosulfate (STS) in children, adolescents and young adults with standard risk medulloblastoma.","volume":"20","author":"Neuwelt","year":"2018","journal-title":"Neuro Oncol"},{"issue":"1","key":"zoi210562r21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"25","key":"zoi210562r22","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss.","volume":"378","author":"Brock","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi210562r23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1124\/jpet.105.087601","article-title":"Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.","volume":"314","author":"Dickey","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"zoi210562r24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1158\/1078-0432.CCR-06-2289","article-title":"Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.","volume":"14","author":"Harned","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"zoi210562r25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40463-019-0327-x","article-title":"A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.","volume":"48","author":"Rolland","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"10","key":"zoi210562r26","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1177\/153537020623101009","article-title":"Kinetics of cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.","volume":"231","author":"Videhult","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"zoi210562r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"2","key":"zoi210562r28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0145445516673998","article-title":"Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data.","volume":"41","author":"Drevon","year":"2017","journal-title":"Behav Modif"},{"issue":"7414","key":"zoi210562r29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"zoi210562r31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis.","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"zoi210562r32","first-page":"493","article-title":"Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.","volume":"7","author":"Doolittle","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"4","key":"zoi210562r33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(ISSN)1096-911X","article-title":"Cisplatin ototoxicity in children: a practical grading system.","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"issue":"12","key":"zoi210562r35","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00405-012-2029-0","article-title":"Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models.","volume":"269","author":"Casares","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"zoi210562r36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000079329","article-title":"Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis.","volume":"66","author":"Lee","year":"2004","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"3","key":"zoi210562r37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/toxics3030268","article-title":"Cisplatin-induced ototoxicity: effects, mechanisms and protection strategies.","volume":"3","author":"Callejo","year":"2015","journal-title":"Toxics"},{"issue":"4","key":"zoi210562r38","first-page":"513","article-title":"Effect of protective agents against cisplatin ototoxicity.","volume":"21","author":"Rybak","year":"2000","journal-title":"Am J Otol"},{"issue":"6","key":"zoi210562r39","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1017\/S0022215113000947","article-title":"Mechanisms of cisplatin ototoxicity: theoretical review.","volume":"127","author":"Gon\u00e7alves","year":"2013","journal-title":"J Laryngol Otol"},{"issue":"4 Pt 2","key":"zoi210562r40","first-page":"1","article-title":"Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.","volume":"103","author":"Schweitzer","year":"1993","journal-title":"Laryngoscope"},{"issue":"6","key":"zoi210562r41","first-page":"731","article-title":"Temporal bone histopathology of cisplatin ototoxicity.","volume":"16","author":"Hinojosa","year":"1995","journal-title":"Am J Otol"},{"issue":"4","key":"zoi210562r42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124881","article-title":"Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats.","volume":"10","author":"Bijarnia","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"zoi210562r43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1039\/C6MT00183A","article-title":"Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.","volume":"8","author":"Sooriyaarachchi","year":"2016","journal-title":"Metallomics"},{"issue":"1","key":"zoi210562r44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2310\/7070.2005.3067","article-title":"Sodium thiosulphate impairs the cytotoxic effects of cisplatin on FADU cells in culture.","volume":"35","author":"Viallet","year":"2006","journal-title":"J Otolaryngol"},{"issue":"3","key":"zoi210562r45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0028-3908(03)00194-1","article-title":"Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.","volume":"45","author":"Wang","year":"2003","journal-title":"Neuropharmacology"},{"issue":"9","key":"zoi210562r46","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00405-020-06003-w","article-title":"Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?","volume":"277","author":"Waissbluth","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"zoi210562r47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.otc.2004.04.003","article-title":"The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption.","volume":"37","author":"Banerjee","year":"2004","journal-title":"Otolaryngol Clin North Am"},{"issue":"4","key":"zoi210562r48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/1040-8428(90)90010-P","article-title":"Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.","volume":"10","author":"Gandara","year":"1990","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"zoi210562r49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF00262275","article-title":"Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate.","volume":"18","author":"Abe","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"zoi210562r50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nm.3155","article-title":"Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration.","volume":"19","author":"Lucas","year":"2013","journal-title":"Nat Med"},{"key":"zoi210562r30","unstructured":"Trial Sequential Analysis. Copenhagen Trial Unit: Centre for Clinical Intervention Research. Accessed June 22, 2021. https:\/\/www.ctu.dk\/tsa\/"},{"key":"zoi210562r34","unstructured":"Ad Hoc Committee on Audiologic Management of Individuals Receiving Ototoxic and\/or Vestibulotoxic Drug Therapy. Audiologic management of individuals receiving cochleotoxic drug therapy: guidelines. American Speech-Language-Hearing Association. Accessed June 28, 2021. https:\/\/www.asha.org\/policy\/gl1994-00003\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2782575\/chen_2021_oi_210562_1627068848.78467.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T13:02:21Z","timestamp":1627909341000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2782575"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18895","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]}}}